Call for Abstract

International Conference on Clinical Pediatrics and Medicine, will be organized around the theme “Dynamic and Collegial approach of Pediatricians”

Pediatric Medicine 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pediatric Medicine 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Pediatric clinical conundrums are some interesting topics of discussion for clinicians around the world. More than theoretical approach a real time case study or case report is more effective to deal with critical situations arising in the hospital. This session will focus on all such case studies and real experiences of paediatricians and other physicians in the hospital. A systematic approach towards better pediatric healthcare will be the main aim of this conference session.

The American Academy of Pediatrics(AAP) started the section on Hospital Medicine with approximately just over 400 members in the year 2005 and presently with the rise in importance of this speciality now has over 2,000 members. With the sole outlook and motive of transitioning patients safely back into the community at the time of their discharge is the aim of every hospitalist. The inpatient teams consisting several sub-specialities and including the patient, family and social and other services coordinate to form an interdisciplinary plan of healthcare that is necessary.This session of the conference will aim to associate with such care givers who are instrumental in providing the best and required treatments to the patients.

  • Track 2-1Pediatric Nephrology
  • Track 2-2Pediatric Genetics and Metabolism
  • Track 2-3Pediatric Emergency Medicine
  • Track 2-4Pediatric Hematology
  • Track 2-5Pediatric Hepatology
  • Track 2-6Pediatric Gastroenterology
  • Track 2-7Pediatric Endocrinology
  • Track 2-8Pediatric Cardiology
  • Track 2-9Pediatric Immunology
  • Track 2-10Pediatric Allergy
  • Track 2-11Pediatric Rheumatology
  • Track 2-12Pediatric Pulmonology
  • Track 2-13Pediatric Oncology
  • Track 2-14Neonatal-Perinatal Medicine

Pediatric drug development is a challenge for over the past half a century. There are quite a few childhood diseases which have significant occurrence rates in pediatric subjects but  for which there are no approved drugs. Reports say that as a result of low prioritization of pediatric drug development globally about 75% of drugs do not carry regulatory approval for use in infants or children; ~66% of medications used in children in the US are used off label, 50% in Europe and in Japan it is less than 20%. Most medications in these regions donot contain package inserts have adequate information for treating infants or children. This session will address all such issues including R&D, F&D and regulatory framework with research scientists from different pharmaceutical industries and also drug discovery researchers.

  • Track 3-1Regulatory framework
  • Track 3-2Dosage form suitability
  • Track 3-3Route of administration
  • Track 3-4Differences in Drug metabolism
  • Track 3-5Differences in Toxicity profiles
  • Track 3-6Differences in Drug response
  • Track 3-7Challenges and opportunities for the future
  • Track 3-8Models for enhancing pediatric drug development
  • Track 3-9Challenges in developing and prescribing drugs for children
  • Track 3-10Patient compliance

A different or modified drug delivery system is required by the pediatric patients compared to other subsets of the population due to their continuing development hence dosing and administration requirements. Conventional formulations are not designed for pediatric patients. Hence it becomes necessity to manipulate and compound the medication accordingly and this has become common practice. The pharmacokinetic and pharmacodynamic profile of a drug varies broadly depending on the factors like developmental stage of a child, necessitating dose flexibility to suit the dosing requirements etc. Excipients which are commonly regarded as safe may pose a safety risk for child group in addition to other considerations of the formulation and development of the dosage form a drug. Palatability and ease of swallowing are also considered as pivotal parametrs for the acceptability of medicines intended for children, who due to their age possess distinct preferences and swallowing abilities than other subsets of the population. New formulation design approaches like multiparticulate drug delivery systems, orodispersible tablets (ODTs), orodispersible films (ODFs), and chewable formulations are gainig importance based on their respective efficacy, PK/PD factors and patient compliances.

  • Track 4-1Solution- Syrups, Elixir
  • Track 4-2Suspension
  • Track 4-3Powders for Reconstitution as Suspension
  • Track 4-4Dispersible and Effervescent Tablets
  • Track 4-5Chewable Tablets
  • Track 4-6Orally Disintegrating Tablets
  • Track 4-7Coated Tablets
  • Track 4-8Sprinkle Oral Powder or Granules

From the time of inception hospitalists have emerged as a fast growing group of physicians in the United States. Reports suggest that in almost 30% hospitals, wherein 55% hospitals consist beds equal to 200 or more, have hospitalists as their medical staffs. Presently, more than 12,000 hospitalists are practicing in the United States. With time if this hospitalist model continues to have expansion at the present rate, the number of hospitalists will eventually rise to 30,000 in the United States by 2019. With its success rate appreciably rising hospitalist programs are adopted in several countries outside North America, including Australia, New Zealand, Argentina, Brazil, Chile, Columbia, Spain, Sweden, and Singapore.

  • Track 5-1Nocturnist
  • Track 5-2Proceduralist
  • Track 5-3Neurohospitalist
  • Track 5-4Surgicalist
  • Track 5-5Admitologist
  • Track 5-6Rounder
  • Track 5-7Allied Health Professionals
  • Track 5-8Medical Students
  • Track 5-9Nurse Practitioners & Physician Assistants

Most hospitalists’ time are engaged in delivering and coordinating the healthcare for a wide range of conditions affecting hospitalized children. Reports say that patients under the care of hospitalists have decreased duration of stay and lesser associated costs when compared to physicians with principally outpatient responsibilities. The range of services provided by a pediatric hospitalist group is by large dependent on the requirement of the situation and the institution. Also the ability of the group to provide these services is an important factor, which may include the following:

Consultation or short-stay observation unit services| Coordinated, family-centered interdisciplinary admission and discharge planning that includes the essential role of the primary care physician| Delivery room services| General inpatient pediatricare| Newborn nursery care| NICU and PICU coverage| Palliative care| Pediatric emergency department evaluation| Perioperative surgical and medical subspecialty care| Sedation services

  • Track 6-1Umbilical Catheterization
  • Track 6-2Endotracheal intubation
  • Track 6-3Arterial and venous blood drawing
  • Track 6-4Percutaneous venous and arterial line placement
  • Track 6-5Lumbar puncture
  • Track 6-6Thoracecentesis
  • Track 6-7Exchange transfusion
  • Track 6-8Suprapubic tap

In the year The Centers for Medicare and Medicaid Services (CMS) have finalized rules that prohibit Medicaid payments for the additional cost of services which result from the preventable healthcare acquired illnesses or injuries, that are generally referred to provider-preventable conditions (PPCs). Basically, there are two distinct categories of PPCs:

1.       Health Care-Acquired Conditions (HCACs)- pertaining to Medicaid inpatient hospital settings

2.       Other Provider-Preventable Conditions (OPPCs)- applying to Medicaid inpatient and outpatient health care settings.

  • Track 7-1Foreign Object Retained After Surgery
  • Track 7-2Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE) Following Certain Orthopedic Procedures:
  • Track 7-3Surgical Site Infection Following Bariatric Surgery for Obesity
  • Track 7-4Surgical Site Infection, Mediastinitis, Following Coronary Artery Bypass Graft (CABG):
  • Track 7-5Vascular Catheter-Associated Infection
  • Track 7-6Catheter-Associated Urinary Tract Infection (UTI)
  • Track 7-7Diabetic Ketoacidosis
  • Track 7-8Manifestations of Poor Glycemic Control
  • Track 7-9Falls and Trauma
  • Track 7-10Stage III and IV Pressure Ulcers
  • Track 7-11Blood Incompatibility
  • Track 7-12Air Embolism
  • Track 7-13Iatrogenic Pneumothorax with Venous Catheterization

Nosocomial infections (NI) are one of the most important causes of morbidity and mortality in pediatric hospitals. Nosocomial (hospital-acquired) infections cause a number of major complications which potent to serious illnesses. Severely ill patients pose a greater risk of acquiring nosocomial infection. This in turn implies to the problem being greatest in intensive care units. However, studies have demonstrated that nosocomial infections are largely preventable. Most Hospital-acquired infections are caused by viral, bacterial, and fungal pathogens. Most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI).

  • Track 8-1Urinary infections
  • Track 8-2 Surgical site infections
  • Track 8-3 Nosocomial pneumonia
  • Track 8-4 Nosocomial bacteraemia
  • Track 8-5 Other nosocomial infections

For diagnosis of nosocomial infections the Laboratory investigations should be additionally guided by the results of detailed physical examination and clinical manifestations. Interpreting laboratory results is critical for nosocomial infections as not all bacterial or fungal growth on a culture are pathogenic. Growth on cultures may often reflect simple microbial colonization. Considering the points like *clinical presentation of the patient *reason for obtaining the test *process by which the specimen was obtained *presence of other supporting evidence of infection

  • Track 9-1Causative organisms and control
  • Track 9-2Blood Culture Collection
  • Track 9-3Vancomycin treatment
  • Track 9-4Ethanol lock therapy (ELT)
  • Track 9-5Carbapenem and Moxifloxacin
  • Track 9-6Penicillin, Gentamicin, And Metronidazole (PGM) Combination Therapy
  • Track 9-7Antifungal therapy
  • Track 9-8Antiviral therapy

Discharge from the hospital for most pediatric patients implies that the child is clinically improving, but all the same it also creates potential risk of the transition of care. In  a study, almost 49% of patients had more than 1 medication error at discharge, which potent to increase their likelihood for readmission. In other studies, approximately 10% to 20% of patients were found to have an adverse event after discharge, with about half of these events deemed to be preventable. It is because of the potential for errors and variability in the discharge process, that recently the Children’s Hospital Association (CHA) formed the first pediatric improvement collaborative to examine whether the shared improvement strategies would affect discharge-related care failures, parent-reported readiness for discharge, and readmission.

  • Track 10-1Patient safety
  • Track 10-2Treatment effectiveness
  • Track 10-3Efficiency
  • Track 10-4Timeliness
  • Track 10-5Equity
  • Track 10-6Patient-centered care

Children—they aren't just miniature adults. Children's perceptions of pediatric nursing care have not been systematically taken into account in the development of the quality of care. Their bodies function differently, absorb medications differently, and process thoughts differently. Starting a normal healthcare regimen early in life enables children to become healthy adults. Nurses, no matter where they work, come into contact with children. It's important to know that children require special handling. Developing trust is key when trying to gain the pediatric patient's cooperation. Understanding the differences in children is important to care for them safely. The family should be included in the child's care, and parent concerns should be taken seriously. Parents can be a valuable tool in assessing and caring for pediatric patients. With the correct knowledge and attitude, treating children and their families can be a wonderful experience.

  • Track 11-1Essentials of pediatric nursing
  • Track 11-2Pediatric care
  • Track 11-3Pediatric dosing
  • Track 11-4Pediatric dose administration
  • Track 11-5Pediatric care
  • Track 11-6Pediatric care
  • Track 11-7Pediatric Nursing education

The Popularity of Herbal medicine over the past 20years has been instrumental in motivating much of this research. Increasing numbers of children and adolescents turn to complementary and alternative medical therapies to promote health, prevent illness, and treat acute and chronic conditions. Herbs are among the most commonly used of these therapies. In 1998, herbs and other dietary supplements were a $3.5 billion dollar industry in the United States.